Government Affairs
Refine Search
Pharmaceutical
The US drug industry is not happy with the Inflation Reduction Act (IRA) and is pursuing broad legal action in an attempt to limit its impact. 22 June 2023
Generics
India's Delhi High Court seeks input from govt on challenge to ban FDC drugs 20 June 2023
Biosimilars
Medicines for Europe has said that it sees the revision of European Union (EU) pharmaceutical legislation as an opportunity to accelerate patient access to safe 15 June 2023
Pharmaceutical
Strengthening regulatory framework, India to join global quality scheme 14 June 2023
Pharmaceutical
Price regulation for non-scheduled drugs in India on hold 13 June 2023
Pharmaceutical
The Biden administration has provided more evidence of its desire to follow rhetoric with action on lowering drug prices through the Inflation Reduction Act (IR 12 June 2023
Pharmaceutical
In mid-2014, the Kingdom of Saudi Arabia (KSA) faced one of the most daunting economic development challenges of its modern history, when crude oil prices colla 9 June 2023
Generics
Russian drugmakers to get additional subsidies for development of generics 9 June 2023
Generics
Indian govt mulling PLI scheme for basic chemicals and API industries 8 June 2023
Pharmaceutical
Indian vaccine majors in talk with Mexico to bolster healthcare 6 June 2023
Pharmaceutical
Findings funded by the US biotech industry suggest the Inflation Reduction Act could have a negative impact on drug development. 2 June 2023
Biotechnology
Seagen stockholders back Pfizer deal, but more hurdles ahead 31 May 2023
Generics
Indian drug majors call for firm stance on Patents Act in FTAs 30 May 2023
Pharmaceutical
UK govt announces £650 million life science funding 26 May 2023
Biosimilars
Need to bolster EU biosimilar medicines policy, says trade group 25 May 2023
Pharmaceutical
A new proposal from the US Department of Health and Human Services (HHS) is proposing steps to further drive down prescription drug costs in Medicaid, building 24 May 2023
Pharmaceutical
With almost 630 applications per year, Belgium is still in the European top three in the number of applications for clinical trials per capita. 22 May 2023
Pharmaceutical
India's chance to drive the global narrative through the G20 presidency 22 May 2023
Generics
Russian drugmakers call for state to simplify launch of domestic generics 22 May 2023
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze